Testosterone Replacement Therapy (TRT)

Medically supervised testosterone replacement therapy (TRT) for men with confirmed low testosterone, andropause or hypogonadism. Available as injectable (Nebido), topical gel or oral tablets, with regular blood monitoring included in the programme.

Testosterone replacement therapy (TRT) at Elyon Clinic is a structured, medically supervised programme for men experiencing the effects of Androgen Deficiency in the Ageing Male (ADAM), also known as andropause or hypogonadism. The clinic's GP-led approach emphasises accurate diagnosis before treatment, transparent pricing with no hidden costs, and ongoing monitoring to ensure safety and efficacy throughout the programme. The diagnostic pathway begins with a detailed consultation reviewing the patient's symptoms — which may include fatigue, reduced libido, mood changes, difficulty maintaining muscle mass, weight gain, poor sleep and cognitive fog — and medical history. A physical examination assesses secondary sexual characteristics and testicular volume. A morning blood test (collected between 8 and 11 AM, when testosterone levels are naturally highest) measures total testosterone alongside LH, FSH, SHBG and prolactin to distinguish primary testicular failure from secondary (pituitary or hypothalamic) hypogonadism. Where indicated, additional tests such as semen analysis, pituitary imaging or a full hormone panel including oestradiol, thyroid function and metabolic markers are ordered. Once low testosterone is clinically confirmed, the doctor discusses the available delivery modalities. Injectable testosterone undecanoate (Nebido) is administered in clinic every three months, making it one of the most convenient options for patients who prefer not to manage daily medication. Topical testosterone gels (such as Testogel or AndroGel) provide stable daily serum levels and are easy to titrate. Oral testosterone preparations offer an alternative for patients in whom injections or gels are unsuitable. Follow-up blood tests at 6 to 12 weeks post-initiation assess haematocrit, oestradiol (which can rise due to peripheral aromatisation), PSA (for men over 40), lipids and liver enzymes. The clinic is clear that TRT can significantly affect sperm production and fertility, and this is discussed candidly with patients considering starting treatment. Ongoing monitoring appointments every three months once the patient is stable ensure that treatment remains within safe and effective parameters. The clinic's no-hidden-costs ethos means patients receive a clear breakdown of consultation, testing and medication fees at the outset, which is particularly valued by patients who have had opaque billing experiences elsewhere. Evening weekday sessions are available for patients who cannot attend during work hours.